![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MRPS17 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS17 mRNA | CTD | PMID:36331819 | MRPS17 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS17 mRNA | CTD | PMID:22206623 | MRPS17 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of MRPS17 mRNA | CTD | PMID:17942748 | MRPS17 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS17 mRNA | CTD | PMID:17942748 | MRPS17 | Human | 17beta-estradiol | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Estradiol results in decreased expression of MRPS17 mRNA | CTD | PMID:19484750 | MRPS17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS17 mRNA | CTD | PMID:17942748 | MRPS17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MRPS17 mRNA | CTD | PMID:34747641 | MRPS17 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mrps17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPS17 mRNA | CTD | PMID:21570461 | MRPS17 | Human | 2,4-dinitrotoluene | affects expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of MRPS17 mRNA | CTD | PMID:21346803 | MRPS17 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of MRPS17 mRNA | CTD | PMID:21179406 | MRPS17 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS17 mRNA | CTD | PMID:28628672 | MRPS17 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Fenretinide results in increased expression of MRPS17 mRNA | CTD | PMID:28973697 | MRPS17 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MRPS17 mRNA | CTD | PMID:30047161 | MRPS17 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of MRPS17 mRNA | CTD | PMID:33167477 | MRPS17 | Human | amitrole | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of MRPS17 mRNA | CTD | PMID:30047161 | MRPS17 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of MRPS17 gene | CTD | PMID:25304211 | MRPS17 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of MRPS17 gene | CTD | PMID:25304211 | MRPS17 | Human | arsenite(3-) | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | arsenite results in increased expression of MRPS17 protein | CTD | PMID:37955338 | MRPS17 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MRPS17 protein] | CTD | PMID:32406909 | MRPS17 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of MRPS17 mRNA | CTD | PMID:22378314 | MRPS17 | Human | azoxystrobin | increases expression | EXP | | 6480464 | azoxystrobin results in increased expression of MRPS17 mRNA | CTD | PMID:33512557 | MRPS17 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of MRPS17 mRNA | CTD | PMID:33754040 | MRPS17 | Human | bisphenol A | affects expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MRPS17 mRNA | CTD | PMID:25181051 | MRPS17 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MRPS17 mRNA and bisphenol A results in decreased expression of MRPS17 protein | CTD | PMID:33670352 and PMID:34186270 | MRPS17 | Human | bisphenol A | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MRPS17 mRNA | CTD | PMID:30816183 and PMID:32528016 | MRPS17 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of MRPS17 protein | CTD | PMID:34186270 | MRPS17 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS17 mRNA | CTD | PMID:28628672 | MRPS17 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of MRPS17 protein | CTD | PMID:34186270 | MRPS17 | Human | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPS17 mRNA | CTD | PMID:29432896 | MRPS17 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MRPS17 mRNA | CTD | PMID:38568856 | MRPS17 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of MRPS17 protein | CTD | PMID:35688186 | MRPS17 | Human | chlorpyrifos | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MRPS17 mRNA | CTD | PMID:37019170 | MRPS17 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of MRPS17 mRNA | CTD | PMID:19549813 | MRPS17 | Human | crocidolite asbestos | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of MRPS17 mRNA | CTD | PMID:29279043 | MRPS17 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS17 mRNA | CTD | PMID:28628672 | MRPS17 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of MRPS17 mRNA | CTD | PMID:37042841 | MRPS17 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of MRPS17 mRNA | CTD | PMID:28302478 | MRPS17 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of MRPS17 mRNA | CTD | PMID:18175754 | MRPS17 | Human | folic acid | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MRPS17 mRNA | CTD | PMID:25629700 | MRPS17 | Human | folic acid | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS17 mRNA | CTD | PMID:22206623 | MRPS17 | Human | gentamycin | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MRPS17 mRNA | CTD | PMID:22061828 | MRPS17 | Human | glycidyl methacrylate | increases expression | EXP | | 6480464 | glycidyl methacrylate results in increased expression of MRPS17 protein | CTD | PMID:36641056 | MRPS17 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of MRPS17 mRNA | CTD | PMID:20044591 | MRPS17 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS17 mRNA | CTD | PMID:28628672 | MRPS17 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of MRPS17 protein | CTD | PMID:32959892 | MRPS17 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of MRPS17 mRNA | CTD | PMID:28988120 and PMID:29427785 | MRPS17 | Human | methimazole | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of MRPS17 mRNA | CTD | PMID:30047161 | MRPS17 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mrps17 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS17 mRNA | CTD | PMID:36331819 | MRPS17 | Human | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of MRPS17 mRNA | CTD | PMID:33512557 | MRPS17 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of MRPS17 mRNA | CTD | PMID:30047161 | MRPS17 | Human | pyrimidifen | increases expression | EXP | | 6480464 | pyrimidifen results in increased expression of MRPS17 mRNA | CTD | PMID:33512557 | MRPS17 | Human | resveratrol | increases expression | ISO | Mrps17 (Mus musculus) | 6480464 | resveratrol results in increased expression of MRPS17 mRNA | CTD | PMID:22610192 | MRPS17 | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of MRPS17 mRNA | CTD | PMID:33512557 | MRPS17 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPS17 protein | CTD | PMID:37664457 | MRPS17 | Human | sodium arsenite | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MRPS17 mRNA | CTD | PMID:16014739 | MRPS17 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MRPS17 mRNA | CTD | PMID:38568856 | MRPS17 | Human | sodium fluoride | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of MRPS17 protein | CTD | PMID:28918527 | MRPS17 | Human | sulfadimethoxine | increases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of MRPS17 mRNA | CTD | PMID:30047161 | MRPS17 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of MRPS17 mRNA | CTD | PMID:31758290 | MRPS17 | Human | thioacetamide | decreases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of MRPS17 mRNA | CTD | PMID:23411599 and PMID:34492290 | MRPS17 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of MRPS17 mRNA | CTD | PMID:38568856 | MRPS17 | Human | titanium dioxide | decreases expression | ISO | Mrps17 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of MRPS17 mRNA | CTD | PMID:23557971 | MRPS17 | Human | titanium dioxide | affects expression | ISO | Mrps17 (Mus musculus) | 6480464 | titanium dioxide affects the expression of MRPS17 mRNA | CTD | PMID:17656681 | MRPS17 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of MRPS17 mRNA | CTD | PMID:37042841 | MRPS17 | Human | triptonide | affects expression | ISO | Mrps17 (Mus musculus) | 6480464 | triptonide affects the expression of MRPS17 mRNA | CTD | PMID:33045310 | MRPS17 | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of MRPS17 mRNA | CTD | PMID:29024780 | MRPS17 | Human | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of MRPS17 mRNA | CTD | PMID:29453283 | MRPS17 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of MRPS17 mRNA | CTD | PMID:28818685 | MRPS17 | Human | vinclozolin | decreases expression | ISO | Mrps17 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of MRPS17 mRNA | CTD | PMID:23034163 | MRPS17 | Human | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MRPS17 mRNA | CTD | PMID:22171008 | MRPS17 | Human | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of MRPS17 mRNA | CTD | PMID:22171008 | |